Press Room

Visit our press room for current and past releases about our company.
November 29, 2017

Vince & Associates, an Altasciences Company, Awarded a $9.5-Million, Five-Year Contract for Clinical Pharmacology Studies

Overland Park, KS (November 29, 2017) — Vince & Associates Clinical Research, an Altasciences company, announced that it has been awarded a contract to carry out clinical pharmacology studies to determine the pharmacokinetics and pharmacodynamics of new medications in humans.

November 29, 2017

Vince & Associates, an Altasciences Company, Awarded a $9.5-Million, Five-Year Contract for Clinical Pharmacology Studies

Overland Park, KS (November 29, 2017) — Vince & Associates Clinical Research, an Altasciences company, announced that it has been awarded a contract to carry out clinical pharmacology studies to determine the pharmacokinetics and pharmacodynamics of new medications in humans.

October 18, 2017

Altasciences Conducts Alcohol Drug-Drug Interaction Study for Amygdala Neurosciences Inc.

Vince & Associates Clinical Research, an Altasciences company, announced today that they are working with Amygdala Neurosciences Inc. to conduct a Phase 1b, proof-of-concept, dose-ranging study to evaluate the safety of the co-administration of ascending doses of ANS-6637 and ethanol in healthy male alcohol drinkers. 

October 11, 2017

Vince & Associates, an Altasciences Company, to Evaluate Marijuana Compound in Clinical Trial

Vince & Associates will conduct an inpatient clinical trial on the psychological effects of an active ingredient in marijuana —  cannabidiol — in support of a federal collaboration seeking to better understand the abuse potential of the substance.

August 25, 2017

Altasciences Clinical Research Offers Innovative Cannabis Research Solutions

Altasciences is pleased to share that they are in the final stages of completing the world’s first safety and tolerability study on a cannabis extract being developed as a new chemical entity for approval by the FDA and Health Canada as a drug.

Pages